Broeckx G, Pauwels P. Malignant peritoneal mesothelioma: a review. Transl Lung Cancer Res. 2018;7(5):537–42. https://doi.org/10.21037/tlcr.2018.10.04.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inagaki N, Kibata K, Tamaki T, et al. Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: a case report and review of the literature. Oncol Lett. 2013;6(3):676–80. https://doi.org/10.3892/ol.2013.1461.

Article  PubMed  PubMed Central  Google Scholar 

Ghimire S, Regmi N, Yang T, et al. Primary malignant mesothelioma of the liver: Case Report and Review of the literature. Eur J Case Rep Intern Med. 2020;7(12):002128. https://doi.org/10.12890/2020_002128.

Article  PubMed  PubMed Central  Google Scholar 

Kottke-Marchant K, Hart WR, Broughan T. Localized fibrous tumor (localized fibrous mesothelioma) of the liver. Cancer. 1989;64(5):1096–102. https://doi.org/10.1002/1097-0142(19890901)64:5<1096::aid-cncr2820640521>3.0.co;2-0.

Article  CAS  PubMed  Google Scholar 

Imura J, Ichikawa K, Takeda J, et al. Localized malignant mesothelioma of the epithelial type occurring as a primary hepatic neoplasm: a case report with review of the literature. APMIS. 2002;110(11):789–94. https://doi.org/10.1034/j.1600-0463.2002.t01-1-1101102.x.

Article  PubMed  Google Scholar 

Leonardou P, Semelka RC, Kanematsu M, et al. Primary malignant mesothelioma of the liver: MR imaging findings. Magn Reson Imaging. 2003;21(9):1091–3. https://doi.org/10.1016/s0730-725x(03)00197-8.

Article  PubMed  Google Scholar 

Di Blasi A, Boscaino A, De Dominicis G, et al. Multicystic mesothelioma of the liver with secondary involvement of peritoneum and inguinal region. Int J Surg Pathol. 2004;12(1):87–91. https://doi.org/10.1177/106689690401200116.

Article  PubMed  Google Scholar 

Gütgemann I, Standop J, Fischer HP. Primary intrahepatic malignant mesothelioma of epithelioid type. Virchows Arch. 2006;448(5):655–8. https://doi.org/10.1007/s00428-006-0175-8.

Article  PubMed  Google Scholar 

Kim DS, Lee SG, Jun SY, et al. Primary malignant mesothelioma developed in liver. Hepatogastroenterology. 2008;55(84):1081–4.

PubMed  Google Scholar 

Sasaki M, Araki I, Yasui T, et al. Primary localized malignant biphasic mesothelioma of the liver in a patient with asbestosis. World J Gastroenterol. 2009;15(5):615–21. https://doi.org/10.3748/wjg.15.615.

Article  PubMed  PubMed Central  Google Scholar 

Dong A, Dong H, Zuo C. Multiple primary hepatic malignant mesotheliomas mimicking cystadenocarcinomas on enhanced CT and FDG PET/CT. Clin Nucl Med. 2014;39(7):619–22. https://doi.org/10.1097/RLU.0b013e31828da61d.

Article  PubMed  Google Scholar 

Perysinakis I, Nixon AM, Spyridakis I, et al. Primary intrahepatic malignant epithelioid mesothelioma. Int J Surg Case Rep. 2014;5(12):1098–101. https://doi.org/10.1016/j.ijscr.2014.11.028.

Article  PubMed  PubMed Central  Google Scholar 

Serter A, Buyukpinarbasili N, Karatepe O, et al. An unusual liver mass: primary malignant mesothelioma of the liver: CT and MRI findings and literature review. Jpn J Radiol. 2015;33(2):102–6. https://doi.org/10.1007/s11604-014-0379-9.

Article  PubMed  Google Scholar 

Haji Ali R, Khalife M, El Nounou G, et al. Giant primary malignant mesothelioma of the liver: a case report. Int J Surg Case Rep. 2017;30:58–61. https://doi.org/10.1016/j.ijscr.2016.11.001.

Article  PubMed  Google Scholar 

Su SS, Zheng GQ, Liu YG, et al. Malignant peritoneum mesothelioma with hepatic involvement: A single institution experience in 5 patients and review of the literature. Gastroenterol Res Pract. 2016;2016:6242149. https://doi.org/10.1155/2016/6242149.

Article  PubMed  PubMed Central  Google Scholar 

Minami K, Okumura H, Hiwatashi K, et al. Multiple malignant epithelioid mesotheliomas of the liver and greater omentum: a case report and review of the literature. Surg Case Rep. 2017;3:66. https://doi.org/10.1186/s40792-017-0342-y.

Article  PubMed  PubMed Central  Google Scholar 

Zhou D, Quan Z, Wang J. Current status of malignant mesothelioma with liver involvement in China: a brief report and review of the literature. Intractable Rare Dis Res. 2018;7(2):112–9. https://doi.org/10.5582/irdr.2018.01052.

Article  PubMed  PubMed Central  Google Scholar 

Huang WJ, Li ZH, Wang Z, et al. Primary malignant mesothelioma of the diaphragm with liver invasion: a case report and review of literature. Med (Baltim). 2019;98(15):e15147. https://doi.org/10.1097/MD.0000000000015147.

Article  Google Scholar 

Ismael H, Cox S. Primary intrahepatic mesotheliomas: a case presentation and literature review. Int J Surg Case Rep. 2018;47:1–6. https://doi.org/10.1016/j.ijscr.2018.04.004.

Article  PubMed  PubMed Central  Google Scholar 

Miyata T, Fujiwara Y, Nishijima K, et al. Localized multiple malignant epithelioid peritoneal mesotheliomas arising from the hepatoduodenal ligament and diaphragm: a case report. J Med Case Rep. 2019;13(1):66. https://doi.org/10.1186/s13256-019-2008. Asian 9.

Article  PubMed  PubMed Central  Google Scholar 

Tanaka T, Miyamoto Y, Sakai A, et al. Nivolumab for malignant peritoneal mesothelioma. BMJ Case Rep. 2020;13(11):e237721. https://doi.org/10.1136/bcr-2020-237721.

Article  PubMed  PubMed Central  Google Scholar 

Pernthaler B, Brcic L, Aigner RM, et al. 18F-FDG PET/CT in primary mesothelioma of the liver. Clin Nucl Med. 2023;48(1):49–51. https://doi.org/10.1097/RLU.0000000000004445.

Article  PubMed  Google Scholar 

Wei C, Sun W, Cui M, et al. Primary sarcomatoid malignant mesothelioma of the liver: A case report. J Surg. 2023;46(9):4058–9. https://doi.org/10.1016/j.asjsur.2023.04.052.

Article  Google Scholar 

Tandon RT, Jimenez-Cortez Y, Taub R, et al. Immunohistochemistry in peritoneal mesothelioma: a single-center experience of 244 cases. Arch Pathol Lab Med. 2022;11(7):1891. https://doi.org/10.3390/jcm11071891.

Article  CAS  Google Scholar 

Li CY, Kennedy T, Alexander HR. Treatment of Patients with Malignant Peritoneal Mesothelioma. J Clin Med. 2022;11(7):1891. https://doi.org/10.3390/jcm11071891.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marchevsky AM, Khoor A, Walts AE, et al. Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel. Mod Pathol. 2020;33(2):281–96. https://doi.org/10.1038/s41379-019-0352-3.

Article  PubMed  Google Scholar 

Kato S, Tomson BN, Buys TP, et al. Genomic Landscape of Malignant Mesotheliomas. Mol Cancer Ther. 2016;15(10):2498–507. https://doi.org/10.1158/1535-7163.MCT-16-0229.

Article  CAS  PubMed  Google Scholar 

Bononi A, Giorgi C, Patergnani S, et al. BAP1 regulates IP3R3-mediated Ca2 + flux to mitochondria suppressing cell transformation. Nature. 2017;546(7659):549–53. https://doi.org/10.1038/nature22798.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fleury-Feith J, Lecomte C, Renier A, et al. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours. Oncogene. 2003;22(24):3799–805. https://doi.org/10.1038/sj.onc.1206593.

Article  CAS  PubMed  Google Scholar 

Tostes FT, Zugman M, Paes VR, et al. Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma. Front Oncol. 2022;12:e007070. https://doi.org/10.3389/fonc.2022.836751.

Article